Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional ...

Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional efficacy and safety data prior to NDA submission of brilaroxazine for the ...

President Donald Trump unveiled a new “Trump class” of Navy battleships Monday, describing them as a superior war fighting vessel to replace an “old and tired and obsolete” US fleet.

This new layer of scrutiny goes beyond criminal records or travel histories. Thus, a 'reputation border' emerges, based not on who you are, but on the trace of your online identity ...

NEW YORK, NY / ACCESS Newswire / December 24, 2025 / Once technology is validated and network effects begin to take hold, the next question investors should ask is simple: how efficiently can this ...

BioCardia®, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces it has completed a third preliminary ...

Trofinetide is a synthetic analog of the N-terminal tripeptide of insulin-like growth factor 1. The mechanism by which ...

In the letter, Ms. Flax and Mr. Plants provide insights on the Company’s recent accomplishments throughout 2025 (including record revenue in its latest quarterly financials), as well as context ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) ...

The USCIS has issued new guidance that limits the age of foreign nationals photos that can be used to create immigration ...

Craig is a reporter for Pocket-lint based in Toronto. He earned a diploma in journalism from Seneca Polytechnic and holds a Media Foundations certificate from Humber College. Craig previously interned ...